Procedure · Houston
Closing the left atrial appendage addresses stroke risk in atrial fibrillation. It is a stroke decision, not a rhythm decision, and it does not treat the AFib itself.
The left atrial appendage is a small pouch off the left atrium. When the atrium fibrillates instead of squeezing, blood moves sluggishly, and in most people with non-valvular atrial fibrillation the clots that cause stroke form in that pouch specifically.
Closing or sealing it removes the most common site where those clots start. A device is placed inside the appendage through a catheter, and over the following weeks the body’s own lining grows across it.
Closure does nothing to the fibrillation. You will still have AFib afterwards. Rate control, rhythm control, and whether ablation belongs on the table are separate conversations that continue unchanged.
People sometimes arrive believing one procedure will settle everything. It will not, and it is better to know that before rather than after.
The candidate is someone with non-valvular AFib whose stroke risk is high enough to warrant anticoagulation, but who has a real reason to seek an alternative to taking it long term — serious or recurrent bleeding, a bleeding source that cannot be fixed, or an occupation or condition that makes a lifetime of anticoagulation genuinely hazardous.
It is not a convenience option for people who would simply rather not take a pill. The evaluation weighs your stroke risk, your bleeding risk, and your anatomy together, and the honest answer for many people is that anticoagulation remains the better plan.
The device is delivered through a vein in the groin and across into the left atrium, guided by imaging — typically transesophageal echo or intracardiac echo — under general anesthesia or deep sedation. Sizing the appendage correctly is the critical step, because the seal has to be complete.
Most people stay one night. Imaging is repeated weeks later to confirm the seal before any change in medication is considered.
You do not walk out of the hospital off anticoagulation. There is a defined period afterwards on blood-thinning medication while the device seals and the lining grows over it, followed by a step down that is confirmed by imaging rather than by the calendar.
The specific regimen and its duration depend on the device and on your bleeding history, and it is individualized. Anyone who describes this as an immediate end to blood thinners is skipping the part that matters.
Bleeding at the access site. Fluid around the heart. Device-related clot. An incomplete seal that leaves a leak. Stroke during or after the procedure. These are uncommon, and they are the reason the decision is made carefully rather than enthusiastically.
Procedures are performed at Houston Methodist, Memorial Hermann, Baylor St. Luke’s, and HCA hospitals across the Texas Medical Center, Clear Lake, and Pearland corridors. Clinic follow-up is at TMC, Clear Lake, or Pearland, Monday–Friday, 8am–5pm. One number: (832) 972-7300.
Dr. Boone evaluates you, performs the procedure, and keeps the follow-up. There is no hand-off to a different physician for the part that matters.
No. It addresses where stroke-causing clots form. The rhythm is unchanged, and it is managed separately.
No. There is a period on medication afterwards while the device seals, and stepping down is confirmed with imaging. The timeline is individualized.
They answer different questions. Ablation is aimed at the rhythm and your symptoms; closure is aimed at stroke risk. Some people are candidates for both, some for neither.
Then anticoagulation is often the better option, and we will say so. Closure earns its place when long-term anticoagulation is genuinely problematic for you.
A visit that reviews your stroke risk, your bleeding history, and imaging of the appendage. Call (832) 972-7300; no referral is needed.
Related: Atrial fibrillation · Catheter ablation · Treatments · Patient guide
Closure is one option among several. The visit is about which one fits your risk, not about the device.
